Terremoto Biosciences | RoundOS

Weekly digest by email

Loading companies…

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Apr 15, 2026	Series C	$108M	BeOne Medicines — Role not disclosedCormorant Asset Management — Role not disclosedDeep Track Capital — Role not disclosedNovo Holdings — Role not disclosedOrbiMed — Role not disclosedOsage University Partners (OUP) — Role not disclosedRA Capital Management — Role not disclosedThird Rock Ventures — Role not disclosed

Investors

BeOne MedicinesSeries C Cormorant Asset ManagementSeries C Deep Track CapitalSeries C Novo HoldingsSeries C OrbiMedSeries C Osage University Partners (OUP)Series C RA Capital ManagementSeries C Third Rock VenturesSeries C

Coverage

Apr 15, 2026Terremoto Biosciences · Series C

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25M · Seed

Sources

terremotobio.com ↗